A new study conducted by the the Catholic University of Korea, College of Medicine, and published in the journal Anticancer Research, has found promising evidence that THC may be the best medicine available to treat stomach cancer, especially when traditional medicine has been ineffective.
Medical Cannabis News & Information
London, United Kingdom: The inhalation of the non-psychoactive cannabinoid CBD (cannabidiol) significantly mitigates tobacco smokers' desire for cigarettes, according to clinical trial data published online in the journal Addictive Behaviors.
Investigators at University College London conducted a double blind pilot study to assess the impact of the ad-hoc consumption of organic CBD versus placebo in 24 tobacco-smoking subjects seeking to quit their habit. Participants were randomized to receive an inhaler containing CBD (n=12) or placebo (n=12) for one week. Trial investigators instructed subjects to use the inhaler when they felt the urge to smoke.
Pharmaceutical painkillers are now responsible for more deaths in the United States than heroin and cocaine combined. The pharmaceuticals are responsible for more than 15,000 deaths conservatively in 2008 alone. With no sign of slowing down, the painkiller industry is becoming wildly popular among Americans — as a result, so is the high rate of painkiller abuse. Classified as dangerous by the U.S. government, cannabis (even in THC-free form, or free of psychoactive effects) has been identified as a powerful pain reliever in more than 80 peer-reviewed studies.
NSAIDs (non-steroidal anti-inflammatory drugs such as ibuprofren) are among the most widely used analgesic substances in the world. However, the consumption of these products is associated with various adverse and life-threatening side-effects such as heart-attack, stroke, and internal bleeding. In fact, according to a 2001 analysis, in the United States alone, “gastrointestinal complications induced by nonsteroidal anti-inflammatory drugs (NSAIDs) cause more than 100,000 hospitalizations and an estimated 16,500 deaths annually.”
Could these adverse gastrointestinal effects be offset by cannabis? A just published study in the European Journal of Pharmacology indicates that the most likely answer is ‘yes.’
Research released earlier this year, conducted by the University of Illinois Department of Medicine, found cannabis to be a helpful treatment for sleep apnea, a condition in which an individual’s breathing slows down, or sometimes stops entirely during sleep and immediately after waking from sleep.
In summary, the research found that even minimal amounts of THC – one of the prime compounds of cannabis – greatly decreased the negative effects of sleep apnea, without any noticeable adverse effects.